According to a new report by Polaris Market Research, the global proteomics market was valued at USD 30.97 billion in 2025 and is projected to reach USD 90.83 billion by 2034, expanding at a CAGR of 12.7% over the forecast period. Growth is underpinned by rising demand for personalized medicine, expanding drug discovery applications, and accelerating research funding across key end-use industries.

What Is Driving Proteomics Market Growth?

Demand is climbing as the growing focus on personalized medicine converges with rising applications of proteomics in pharmaceutical drug discovery. Manufacturers and researchers are prioritizing protein-based biomarker identification, pushing proteomics adoption across clinical diagnostics, molecular medicine, and drug development. Polaris analysts note that increasing government and private research funding positions the segment for sustained growth through 2034, with drug discovery emerging as the largest revenue contributor and clinical diagnosis posting the fastest incremental gains.

Key Trends Shaping the Proteomics Industry

Advanced Mass Spectrometry Adoption

Next-generation mass spectrometry technologies are enhancing the sensitivity, speed, and resolution of protein analysis, enabling identification and quantification of a greater number of proteins from smaller sample sizes.

AI and Machine Learning Integration

AI and ML algorithms are increasingly applied to analyze complex proteomic datasets, enabling more efficient biomarker discovery, drug target identification, and disease prediction.

Growing Emphasis on Personalized Medicine

Proteomics plays a crucial role in developing personalized medicine biomarkers and therapies by identifying individual-specific protein biomarkers for diagnosis, prognosis, and treatment monitoring.

Market Segmentation: Breaking Down the Proteomics Market

Polaris segments the proteomics market by product type, application, technology, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Product Type

The reagents & consumables segment holds the largest market share, given their fundamental role in protein extraction, purification, labeling, and analysis. The services segment is projected to register the highest growth rate as the complexity of proteomic studies increases demand for specialized protein identification, quantification, and characterization expertise.

By Application

Drug discovery holds the largest share of the market, driven by extensive use of proteomics in identifying drug targets and evaluating efficacy and toxicity. Clinical diagnosis is projected to post the highest growth rate, fueled by rising application of proteomic technologies in disease-specific biomarker identification.

By Technology

Spectroscopy accounts for the largest market share, led by widespread adoption of mass spectrometry for protein identification and quantification. Surface plasmon resonance (SPR) systems are the fastest-growing technology segment, driven by rising demand for label-free, real-time analysis of biomolecular interactions.

Regional Outlook: Where Is Proteomics Growing Fastest?

North America held the largest share of the proteomics market in 2024, supported by a robust research ecosystem, leading academic institutions, and significant government funding through bodies such as the National Institutes of Health. Europe also maintains a significant market presence given its strong life sciences research infrastructure. Asia Pacific is projected to register the highest growth rate during the forecast period, driven by rising investments in healthcare infrastructure and expanding pharmaceutical and biotechnology sectors in China, India, and Japan.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/proteomics-market 

Competitive Landscape: Leading Proteomics Companies

Key players profiled in the report include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., and Bruker Corporation, who are focusing on advanced mass spectrometry, bioinformatics tools, and strategic acquisitions to strengthen market position across the reagents & consumables and drug discovery segments outlined above. Recent moves include Thermo Fisher Scientific's July 2024 completed acquisition of Olink Holding AB for USD 3.1 billion, strengthening its next-generation proteomics portfolio, and Bruker Corporation's May 2024 opening of a new mass spectrometry manufacturing facility in Bremen, Germany.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the proteomics market, this report benchmarks market share, segment-level pricing, and forecast data — by product type, application, technology, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking clinical diagnosis as a growth adjacency.

More Trending Latest Reports By Polaris Market Research:

Non-Human Primate Pre-clinical studies at Contract Research Organizations Market

Wastewater Reverse Osmosis Membrane Market

Acrylonitrile Butadiene Styrene Market

Pad-mounted Switchgear Market

Wastewater Reverse Osmosis Membrane Market

Solar Panels Market

Scooters Market

The Growing Potential of the Transformer Oil Market

Compressed Natural Gas (CNG) Market